Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.

<p>In the recurrence group, BCVA (logMAR ± standard deviation) showed no significant change from baselines (0.37 ± 0.20) to 0.35 ± 0.23, 0.35 ± 0.18, 0.31 ± 0.23, 0.34 ± 0.26, 0.28 ± 0.30, and 0.24 ± 0.23 at 1, 3, 6, 12, 24, and 36 months, respectively (Kruskal–Wallis test, P = 0.45). In contr...

Full description

Saved in:

Bibliographic Details
Main Author:	Yasuyuki Sotani (20114144) (author)
Other Authors:	Hisanori Imai (9510209) (author), Hiroko Yamada (789443) (author), Akiko Miki (337892) (author), Makoto Nakamura (199152) (author)
Published:	2025
Subjects:	Medicine Cell Biology Neuroscience Science Policy Mental Health Biological Sciences not elsewhere classified retinal vein occlusion promising surgical option kobe university hospital fibrinogen clot removal crt significantly decreased corrected visual acuity average annual number mean bcva improved crt ), number outpatient visits decreased managing refractory rvo 4 &# 956 2 &# 956 year clinical outcomes total treatments decreased year outcomes outpatient visits clinical parameters 001 ), xlink "> september 2014 rvo ). retrospectively analyzed resolution preoperatively nine eyes minimum follow minimum angle microaneurysm photocoagulation mean age july 2021 eight eyes 24 logarithm 23 patients 23 eyes 13 females 001 ).
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.

Similar Items